15:08:43 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-12 Bokslutskommuniké 2024
2024-08-23 Kvartalsrapport 2024-Q2
2024-06-07 Årsstämma 2024
2024-04-26 Bokslutskommuniké 2023
2023-08-24 Kvartalsrapport 2023-Q2
2023-06-12 Ordinarie utdelning ABTEC 0.00 NOK
2023-06-09 Årsstämma 2023
2023-04-28 Bokslutskommuniké 2022
2022-08-24 Kvartalsrapport 2022-Q2
2022-06-10 Ordinarie utdelning ABTEC 0.00 NOK
2022-06-09 Årsstämma 2022
2022-04-29 Bokslutskommuniké 2021
2021-08-25 Kvartalsrapport 2021-Q2
2021-06-10 Ordinarie utdelning ABTEC 0.00 NOK
2021-06-09 Årsstämma 2021
2021-04-30 Bokslutskommuniké 2020
2020-09-11 Extra Bolagsstämma 2020
2020-08-26 Kvartalsrapport 2020-Q2
2020-06-11 Ordinarie utdelning ABTEC 0.00 NOK
2020-06-10 Årsstämma 2020
2020-04-15 Bokslutskommuniké 2019
2019-08-28 Kvartalsrapport 2019-Q2
2019-06-06 Ordinarie utdelning ABTEC 0.00 NOK
2019-06-05 Årsstämma 2019
2019-04-24 Bokslutskommuniké 2018
2019-01-07 Extra Bolagsstämma 2019
2018-08-22 Kvartalsrapport 2018-Q2
2018-05-30 Årsstämma 2018
2018-02-21 Bokslutskommuniké 2017
2017-08-16 Kvartalsrapport 2017-Q2
2017-06-08 Ordinarie utdelning ABTEC 1.00 NOK
2017-06-07 Årsstämma 2017
2017-02-15 Bokslutskommuniké 2016
2016-11-18 Bonusutdelning ABTEC 1
2016-11-17 Kvartalsrapport 2016-Q3
2016-11-17 Extra Bolagsstämma 2016
2016-08-17 Kvartalsrapport 2016-Q2
2016-06-09 Ordinarie utdelning ABTEC 1.50 NOK
2016-06-08 Årsstämma 2016
2016-05-11 Kvartalsrapport 2016-Q1
2016-02-10 Bokslutskommuniké 2015
2015-11-18 Kvartalsrapport 2015-Q3
2015-08-19 Kvartalsrapport 2015-Q2
2015-06-04 Ordinarie utdelning ABTEC 1.00 NOK
2015-06-03 Årsstämma 2015
2015-05-13 Kvartalsrapport 2015-Q1
2015-02-11 Bokslutskommuniké 2014
2014-11-26 Kvartalsrapport 2014-Q3
2014-08-20 Kvartalsrapport 2014-Q2
2014-06-11 Årsstämma 2014
2014-05-21 Kvartalsrapport 2014-Q1
2014-02-12 Bokslutskommuniké 2013
2013-11-27 Kvartalsrapport 2013-Q3
2013-08-21 Kvartalsrapport 2013-Q2
2013-06-13 Kapitalmarknadsdag 2013
2013-06-12 Ordinarie utdelning
2013-06-11 Årsstämma 2013
2013-05-22 Kvartalsrapport 2013-Q1
2013-02-13 Bokslutskommuniké 2012
2012-11-27 Kvartalsrapport 2012-Q3
2012-08-28 Kvartalsrapport 2012-Q2
2012-06-14 Årsstämma 2012
2012-05-23 Kvartalsrapport 2012-Q1
2012-02-17 Bokslutskommuniké 2011
2011-11-30 Kvartalsrapport 2011-Q3
2011-08-29 Kvartalsrapport 2011-Q2
2011-06-17 Ordinarie utdelning
2011-06-16 Årsstämma 2011
2011-05-30 Kvartalsrapport 2011-Q1
2011-02-18 Bokslutskommuniké 2010

Beskrivning

LandNorge
ListaOAX Equities
SektorHälsovård
IndustriBioteknik
Aqua Bio Technology är ett norskt bolag verksamma inom kosmetikabranschen. Bolaget utvecklar, tillverkar och kommersialiserar ingredienser som används inom ett flertal kosmetiska produkter världen över. Störst verksamhet återfinns inom lösningar för hudvårdsprodukter. Merparten av bolagets produkter säljs på en global marknad via diverse distributörer. Bolaget grundades 2004 och har sitt huvudkontor i Lysaker.
2023-08-21 13:36:59
21.8.2023 13:36:56 CEST | Aqua Bio Technology ASA | Additional regulated
information required to be disclosed under the laws of a member state

Reference is made to the stock exchange notice by Aqua Bio Technology ASA (the "
Company") on 8 August 2023 regarding a subsequent offering with gross proceeds
of up to NOK 5,000,001 through issuance of up to 1,666,667 new shares at a
subscription price of NOK 3.00 per share (the "Subsequent Offering"). In the
Subsequent Offering, the shareholders of the Company as of 23 July 2023 (as
registered in the VPS on 25 July 2023), except: (i) shareholders that subscribed
for shares in the private placement placed on 23 July 2023, and (ii)
shareholders who are resident in a jurisdiction where such offering would be
unlawful, or would require any prospectus filing, registration or similar action
(the "Eligible Shareholders"), received subscription rights giving preferential
rights to subscribe for and be allocated new shares in the Subsequent Offering
(the "Offer Shares"). In addition, certain groups of investors, as described in
the stock exchange notice dated 8 August 2023 were given a secondary right to
subscribe for Offer Shares not subscribed for by the Eligible Shareholders.

The application period in the Subsequent Offering ended on 18 August at 16.30
CEST. At the end of the application period, the Company had received
applications corresponding to an oversubscription of approximately 270,000 Offer
Shares. The new shares will be subscribed both through subscription rights and
from Secondary Subscribers.

The Company's board of directors (the "Board") has now allocated shares in the
Subsequent Offering, which implies that the Company shall issue 1,666,667 new
shares related to the Subsequent Offering. The Board has allocated 1,442,978
Offer Shares to Eligible Shareholders and 270,644 Offer Shares to Secondary
Subscribers. Allocation letters, regarding the number of shares allocated and
the subscription amount to be paid, will be distributed to the subscribers
shortly.

Completion of the Subsequent Offering is subject to approval of the share
capital increase pertaining to the Subsequent Offering in the extraordinary
general meeting of the Company to be held on 24 August 2023. Shareholders
representing more than 2/3 of the shares in the Company has entered into voting
undertakings where they have undertaken to vote in favour of such resolution.

For further information, please contact Håvard Lindstrøm, CEO, telephone +47
9413 2288.

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/2553/3557/Download%20announcement
%20as%20PDF.pdf